[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368713-105":59,"doc-detail-368713-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tlr9-downregulation-in-breast-cancer-its-role-in-tumor-immunity-inflammatory-response-and-cellular-senescence","TLR9 Downregulation in Breast Cancer - Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence","","TLR9, a DNA-sensing Toll-like receptor, is investigated for its altered activity in breast cancer and its impact on tumor biology. The study uses patient biopsies and immunohistochemistry to assess TLR9 expression in tumor versus normal epithelium, and evaluates downregulation in transformed breast cancer cell lines. Engineered MDA-MB-361 cells expressing exogenous TLR9 show reduced colony growth and increased senescence-associated and pro-inflammatory signals, linking innate immunity regulation to tumor cell growth control.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tlr9-downregulation-in-breast-cancer-its-role-in-tumor-immunity-inflammatory-response-and-cellular-senescence/368713/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tlr9-downregulation-in-breast-cancer-its-role-in-tumor-immunity-inflammatory-response-and-cellular-senescence/368713.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is TLR9 and why is it important in this study?","Question",{"text":112,"@type":113},"TLR9 is a DNA-sensing Toll-like receptor that recognizes double-stranded DNA motifs and can drive inflammatory signaling. This paper examines how changes in TLR9 relate to breast cancer progression and immune regulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was TLR9 expression measured in breast cancer tissues and cell lines?",{"text":117,"@type":113},"TLR9 expression was assessed in patient biopsies using immunohistochemistry, and evaluated in transformed versus untransformed breast epithelial cell lines using gene or protein expression analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What effects occur when breast cancer cells express exogenous TLR9?",{"text":121,"@type":113},"Cells expressing exogenous TLR9 exhibit reduced colony growth and increased senescence markers, including IL-6, and enhanced pro-inflammatory mediators such as CCL2, CXCL1, and GM-CSF.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368713,1790805906,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Journal of  \nInnate Immunity  \nResearch Article  \nJ Innate Immun 2025;17:354–368 DOI: 10. 1159/000545527  \nReceived: September 12, 2024  \nAccepted: March 18, 2025  \nPublished online: June 23, 2025  \nTLR9 Downregulation in Breast Cancer: Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence  \nEmily Siblea Gregory Weitsman b, c Salome Amouyala Guillaume Roblot a Marie Marotela Rémi Pescarmonaa Nathalie Bendriss-Vermared  \nCheryl Gillette Amie Ceesaya Alexia Gazeuc Marie Cecile Michalletc Christophe Caux c Francois-Loic Cosset a Umaima Al Alemf Tony Ngb Uzma Ayesha Hasana, d  \naCentre International de recherche en Infectiologie, CIRI, Inserm, U1111, Lyon, France; bKing’s College London, London, UK; cDivision of Cancer Studies, Research Oncology, Guy’s Hospital, King’s College London, London, UK; dCancer Research Centre of Lyon, CRCL, INSERM U1052-CNRS UMR5286, Lyon, France; eSchool of Cancer on Pharmaceutical Sciences, King’s College London, Guy’s Campus, London, UK; fDivision of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, IL, USA  \nKeywords  \nTLR9 · Breast cancer · Cell cycle · Senescence  \ncytokine analysis, and flow cytometry. Results: TLR9 levels in breast cancer tumors were significantly reduced compared to normal breast tissue epithelium. This downregulation was also observed in several transformed breast cancer cell lines com-  \nAbstract  \nIntroduction: Toll-like receptor 9 (TLR9) is primarily expressed inhuman dendritic and B cells and recognizes double-stranded DNA motifs from pathogens to initiate an inflammatory response. Recent studies have revealed TLR9s’ involvement beyond its conventional role in the immune response, notably during the tumorigenesis of various cancers such as head and neck, cervical, and ovarian cancers. Methods: In this study patient biopsies of breast cancer tumors and normal breast epithelium were analyzed by immunohistochemistry to examine TLR9 expression. The study also investigated downregulation in transformed breast cancer cell lines compared to untransformed breast epithelial cells by analyzing gene or protein expression, including TLR9, IL-6, CCL2, CXCL1, and GMCSF. MDA-MB-361 cells were engineered to express exogenous TLR9, and the effects on colony growth and senescence were assessed using colony formation assays, senescence staining,  \npared to untransformed breast epithelial cell lines. Furthermore, MDA-MB-361 breast cancer cells expressing exogenous TLR9 exhibited reduced colony growth and an increase in the senescence marker IL-6, pro-inflammatory cytokine CCL2, CXCL1 chemokine; and growth factor GM-CSF. Conclusion: These findings support TLR9’s regulatory role in mitigating breast cancer and highlight its critical connection between the innate immunity and tumor cell growth. © 2025 The Author(s) .  \nPublished by S. Karger AG, Basel  \nIntroduction  \nBreast cancer (BC) is the most frequently diagnosed cancer in women worldwide [ 1], where 1 in every 6 cases ends in death [2] . Current studies predict an everincreasing global burden on premenopausal women  \n[karger@karger.com](karger@karger.com)[ ](karger@karger.com)[www.karger.com/jin](www.karger.com/jin)  \n© 2025 The Author(s) .  \nPublished by S. Karger AG, Basel  \nThis article is licensed under the Creative Commons AttributionNonCommercial 4.0 International License (CC BY-NC) ([https://](https://)[ ](https://)[karger.com/Services/OpenAccessLicense](karger.com/Services/OpenAccessLicense)). Usage and distribution for commercial purposes requires written permission.  \nCorrespondence to:  \nUzma Ayesha Hasan, [uzma.hasan](uzma.hasan@inserm.fr)[@](uzma.hasan@inserm.fr)[inserm.fr](uzma.hasan@inserm.fr)  \ndue to environmental factors and postmenopausal women susceptible to age-related risk factors [3] . BC metastasis begins in the transformed epithelium-where early detection and treatment is critical for a favorable prognosis [4] . However, the BC tumor microenvironment (TME) is heteroge","cbCaiegMIPzWr1Px","https://ap.wps.com/l/cbCaiegMIPzWr1Px","pdf",4608095,15,"English","# Introduction\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What is TLR9 and why is it important in this study?\",\"answer\":\"TLR9 is a DNA-sensing Toll-like receptor that recognizes double-stranded DNA motifs and can drive inflammatory signaling. This paper examines how changes in TLR9 relate to breast cancer progression and immune regulation.\"},{\"question\":\"How was TLR9 expression measured in breast cancer tissues and cell lines?\",\"answer\":\"TLR9 expression was assessed in patient biopsies using immunohistochemistry, and evaluated in transformed versus untransformed breast epithelial cell lines using gene or protein expression analyses.\"},{\"question\":\"What effects occur when breast cancer cells express exogenous TLR9?\",\"answer\":\"Cells expressing exogenous TLR9 exhibit reduced colony growth and increased senescence markers, including IL-6, and enhanced pro-inflammatory mediators such as CCL2, CXCL1, and GM-CSF.\"}]","TLR9 Downregulation in Breast Cancer - Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence | PDF",1790178153,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b58f18ed3d7cffae48afd8025f63531a.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3214accd4b5ae0d7111c9dd2f731d5ae.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9802bd9f8899ada21d2c4386d411e16.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/074ffbf7650cb5a83228bf6f323822f8.webp",980,1306]